Skip to content

Zantac Lawsuit Investigation Pending Possible Zantac Cancer Connection

Oct 26, 2020
Shamis & Gentile, P.A.
Zantac Lawsuit Information - cancer connection

Have you taken Zantac or its generic form, ranitidine, and then later been diagnosed with cancer? Then you may be eligible for participation in a Zantac lawsuit investigation. Zantac lawyers want anyone who was potentially impacted by Zantac to know that they may be eligible for a Zantac lawsuit investigation. Please read on to find out more about this important information.

First, a quick glance at the situation at hand.

  • Who May Be Impacted?
    Anyone who took Zantac, the brand name for ranitidine, may be be eligible for a potential lawsuit investigation. Zantac is the brand name for ranitidine, a medication commonly used for heartburn, reflux disease and similar problems.
  • What Is The Problem?
    There have been recent claims, backed by an independent lab study, that may connect the use of Zantac with an increased risk for certain types of cancers. The lawsuit investigations are trying to determine whether or not lawsuits may be filed in order to help those affected get proper compensation.
  • Should I Consult a Lawyer?
    If you have taken Zantac and were later diagnosed with cancer, then you should contact Zantac lawsuit lawyers for more information about possible actions.

More Information That Zantac Lawsuit Lawyers Want You to Know

In addition to the brief information above, it is important for anyone potentially impacted by these issues to understand more about the situation. This is especially important for anyone interested in the Zantac lawsuit investigation, as lawsuits have already been filed ins one cases.

NDMA Present in Ranitidine

The first confirmed lawsuit related to Zantac and a potential increased risk for cancer were filed after Valisure, an online pharmacy, detected significantly high levels of NDMA (nitrosodiumethylamine) in every single batch of ranitidine products that they tested; these batches include batches of Zantac. The tests conducted by Valisure attributed the presence of NDMA to the inherit instability of ranitidine, which then caused a reaction that produced NDMA. In the tests performed by Valisure, there were an excess of 3 million nanograms of NDMA per tablet; this is more than 31,000 the maximum daily intake as recommended by the FDA.

Although the initial response of the FDA was lukewarm, the FDA recently conduced its own testing and confirmed “unacceptable levels” of NDA present in its samples of ranitidine products. In April of 2020, the FDA officially requested the manufacturers recall all ranitidine medications, including Zantac; they also recommended that people stop taking over the counter products (such as Zantac) and that people with prescription ranitidine consult with their physicians.

Why Are Lawsuits Being Filed?

Zantac lawyers filed lawsuits because it is alleged that Sanofi, the manufacturer of Zantac, was aware that Zantac’s reaction to the body would cause the production of NDMA; and that this NDMA, which is considered a probable carcinogen linked to increased cancer risk, was far above the maximum daily intake as recommended by the FDA. According to the lawsuit claims, Sanofi knew these risks but did not warn users about them.

You may be entitled for compensation for medical bills, lost wages, as well as compensation for mental anguish and physical pain.

Contact Zantac Lawyers Today

Do you believe you may be eligible for a Zantac investigation or lawsuit?

Then please contact your Zantac Lawyers, Shamis & Gentile, P.A. for a free case review at; or call us today 305-479-2299.

Submit a Class Action Claim

Submit a class action claim today; there are no associated fees or expenses unless we manage to win the case on your behalf.